accountfavorable currency exchange rates. First-quarter revenue got a boost of $224 million from sales of products made by King Pharmaceuticals, a maker of abuse-resistant and other pain drugs that Pfizer acquired on March 1 for $3.6 billion. Sales were driven...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer 1Q profits rise 10% on lower costs, taxes
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account